Concepedia

Yaru Shi

YS

11

Publications

306

Citations

10

H-Index

2018

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Tianjin Medical University

University of Colorado Anschutz Medical Campus

George Washington University

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Yaru Shi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

2018–2025

11

Publications

11

A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)

Heather Platt, José F. Cardona, Miwa Haranaka et al. · Vaccine · 2021 · 88 citations · Full text

Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death

Marc Humbert, Vallerie V. McLaughlin, David B. Badesch et al. · New England Journal of Medicine · 2025 · 64 citations

A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice

Yuanyuan Kuang, Veronica Zorzi, Damiano Buratto et al. · EBioMedicine · 2020 · 36 citations · Full text

miR‐196b‐5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF‐β signaling

Yaru Shi, Fang Li, Shan Wang et al. · The FASEB Journal · 2020 · 18 citations

, , +15

Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia/reperfusion injury through alleviating reactive oxygen species production in hepatocytes

Qingping Li, Jianping Qian, Yiyi Li et al. · Free Radical Biology and Medicine · 2020 · 18 citations

, , +13

Rows per page

1–5 of 11